Structure of PDB 6cn5 Chain B Binding Site BS01 |
|
|
Ligand ID | F7M |
InChI | InChI=1S/C28H31N5O2/c1-32-18-24(20-10-13-33(14-11-20)28(35)21-5-3-2-4-6-21)23-16-22(7-8-26(23)32)31-27(34)25-15-19(17-29)9-12-30-25/h7-9,12,15-16,18,20-21H,2-6,10-11,13-14H2,1H3,(H,31,34) |
InChIKey | LRJCIDHTWFKTMZ-UHFFFAOYSA-N |
SMILES | Software | SMILES |
---|
ACDLabs 12.01 | c1n(c4c(c1C3CCN(C(C2CCCCC2)=O)CC3)cc(cc4)NC(=O)c5cc(ccn5)C#N)C | OpenEye OEToolkits 2.0.6 | Cn1cc(c2c1ccc(c2)NC(=O)c3cc(ccn3)C#N)C4CCN(CC4)C(=O)C5CCCCC5 | CACTVS 3.385 | Cn1cc(C2CCN(CC2)C(=O)C3CCCCC3)c4cc(NC(=O)c5cc(ccn5)C#N)ccc14 |
|
Formula | C28 H31 N5 O2 |
Name | 4-cyano-N-{3-[1-(cyclohexanecarbonyl)piperidin-4-yl]-1-methyl-1H-indol-5-yl}pyridine-2-carboxamide |
ChEMBL | CHEMBL4281109 |
DrugBank | |
ZINC |
|
PDB chain | 6cn5 Chain B Residue 601
[Download ligand structure]
[Download structure with residue number starting from 1]
[View ligand structure]
|
|
|
Global view | Local view | Structure summary |
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
PDB | 6cn5 Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist. |
Resolution | 2.3 Å |
Binding residue (original residue number in PDB) | Q286 L287 C320 H323 M365 A368 V376 F377 F388 I397 I400 F401 H479 |
Binding residue (residue number reindexed from 1) | Q22 L23 C56 H59 M101 A104 V112 F113 F124 I133 I136 F137 H215 |
Annotation score | 1 |
Binding affinity | MOAD: Ki=0.02uM BindingDB: IC50=120nM,Ki=20nM |
|
|
Enzyme Commision number |
? |
|
|
|